论文部分内容阅读
目的:评价胺碘酮对急性心肌梗死伴室性心律失常的临床疗效。方法:选取心内科2014年2月—2015年3月间收治的急性心肌梗死伴室性心律失常患者80例,按照治疗方法的不同将其分为治疗组和对照组,每组40例;对照组患者给予利多卡因治疗,治疗组患者均给予胺碘酮治疗,比较两组患者治疗后的总有效率和用药期间不良反应的发生率。结果:治疗组患者治疗后的总有效率为77.50%高于对照组为47.50%(P<0.05)。结论:在临床治疗急性心肌梗死患者的过程中,采用胺碘酮治疗急性心肌梗死伴室性心律失常的疗效较为显著,优于利多卡因,且不良反应的发生率低。
Objective: To evaluate the clinical effect of amiodarone on acute myocardial infarction with ventricular arrhythmia. Methods: Eighty patients with acute myocardial infarction with ventricular arrhythmia admitted from February 2014 to March 2015 in our department of cardiology were divided into treatment group (40 cases) and control group Lidocaine was given to the patients in the treatment group. Amiodarone was given to the patients in the treatment group. The total effective rate and the incidence of adverse reactions during the treatment were compared between the two groups. Results: The total effective rate of the treatment group after treatment was 77.50% higher than that of the control group (47.50%, P <0.05). Conclusions: In the clinical treatment of patients with acute myocardial infarction, the effect of amiodarone in the treatment of acute myocardial infarction with ventricular arrhythmia is more significant, superior to lidocaine, and the incidence of adverse reactions is low.